Andrea Sarturi
Senior Associate
Get their honest, personalized take on your startup.
Sign in to pitch Andrea →At a glance
- Full Name
- Andrea Sartori
- Title
- Director, Investment Team
- Firm
- Cobepa (formerly Chequers Capital)
- Firm Type
- Private equity / long-term "permanent capital" investment company (mid-market buyout and growth)
- Investment Stage
- Established, cash-generative mid-market companies (buyouts / majority and significant-minority stakes) — not angel or seed
- Check Size
- Not publicly disclosed; Cobepa invests off a permanent balance sheet (NAV >€5.5bn as of Dec 2024), typically in mid-to-large-cap private companies
- Target Company Profile
- Solid, growing, often family-owned businesses with defensible market positions and strong management teams
- Sector Focus
- Industrials, manufacturing, consumer/branded goods, and diversified B2B businesses (Cobepa is generalist)
- Geographic Focus
- Europe (with a particular personal focus on Southern Europe / Italy) and North America
- Location
- Brussels, Belgium
Background
Andrea Sartori is an Italian private-equity investor based in Brussels, where he is a Director on the investment team at Cobepa, an independent, privately held long-term investment company. He joined Cobepa in 2020 and has since taken board seats at portfolio companies including Salice (premium furniture fittings and opening systems) and Crealis (capping and overcapping solutions for wines and spirits).
Before Cobepa, Sartori spent about three years at Chequers Capital, a pan-European mid-market private-equity fund headquartered in Paris (founded 1972, ~€1.5bn in resources, nearly 300 investments across France, Germany, Italy, Spain, Belgium and the UK). At Chequers he focused on Southern European opportunities. The stub's Chequers email and Paris phone number date from this period.
Earlier in his career, Sartori held positions in Milan at BNP Paribas (Leveraged Finance) and at DeA Capital / DeA Capital Alternative Funds SGR, giving him a grounding in both debt financing and fund investing before moving to direct equity.
He holds a Master's Degree with Honors in Business Administration and Law (MSc, 2012–2015) from Bocconi University (Università Commerciale "Luigi Bocconi") in Milan. He speaks Italian, English and French.
Investment Thesis & Focus
- Invests in established, cash-generative mid-market companies — buyouts and majority/significant stakes — rather than early-stage or seed deals.
- At Cobepa, uses a permanent-capital, long-horizon model: the firm states it "can accompany and support its investee companies with a flexible investment horizon," reinvesting divestment gains rather than operating to fixed fund lifetimes.
- Favors solid, growing, often family-owned businesses with strong management, then supports buy-and-build growth (e.g., Salice's bolt-on acquisitions of Villes and Atim under Cobepa ownership).
- Cobepa's stated philosophy: success "lies in taking decisive action and calculated risks," partnering with management to "enhance the growth perspectives of our investments as well as the sustainability of their business model."
- Personal specialization in Italy and Southern Europe, reflecting his Bocconi background and Milan-based early career.
Notable Investments
- Salice (Arturo Salice S.p.A.) — Italian family-owned maker of premium furniture hinges, fittings and opening systems; Cobepa acquired a majority stake, closing June 2022. Sartori is a board member. Salice has since made bolt-on acquisitions (Villes 2000, Atim).
- Crealis — global leader in capping and overcapping solutions for wines and spirits; a Cobepa portfolio company on which Sartori serves as a director/board member.
- Chequers Capital (2017–2020, approx.) — worked on the firm's pan-European mid-market buyout deals with a Southern Europe focus; specific named deals from his tenure are not individually attributed in public sources.
Unlock the full research
Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.
One-time. Stays unlocked for you.